Skip to Content

Infusion Services

The infusion services sector is undergoing significant growth and transformation as demand for specialty therapies expands and care continues shifting toward lower-cost outpatient settings. Agenda Health works with infusion services business owners to help them navigate this evolving market and successfully position their companies for strategic transactions.

Infusion Services

A Rapidly Expanding Infusion Services Market

Infusion therapy has become one of the fastest-growing segments of specialty healthcare. Today, more than 3.2 million Americans receive infusion therapy annually, representing substantial growth over the past decade. Industry spending now exceeds $110 billion per year, supported by increasing prevalence of chronic disease, advances in biologic therapies, and expanding treatment options.

The market is also evolving in how and where care is delivered. Infusion services are increasingly shifting away from hospital-based settings toward ambulatory infusion centers, physician offices, and home infusion models that offer greater convenience and lower costs. At the same time, the sector remains highly fragmented, with hundreds of independent providers operating across the country.

Agenda Health closely tracks these industry dynamics—including reimbursement trends, site-of-care shifts, and payer strategies—to help infusion providers understand where the market is headed and how their businesses fit into it.

Infusion Services
Infusion Services
Infusion Services

A Strong and Active M&A Landscape

Investor interest in infusion services has remained strong as healthcare investors seek scalable platforms in high-growth specialty sectors.

Private equity firms and strategic buyers continue to pursue infusion platforms that demonstrate operational scale, diversified therapeutic offerings, and strong payer relationships. Recent acquisitions across the home and alternate site infusion space highlight continued investor demand for well-positioned platforms and confirm the strategic importance of infusion services within the broader healthcare landscape.

This demand is driven by the sector’s long-term fundamentals: growing patient populations, expanding specialty drug pipelines, and continued movement toward cost-efficient sites of care. For infusion services owners, these dynamics have created a favorable environment for partnerships, recapitalizations, and full exits.

Positioning Infusion Businesses for Maximum Value

Successfully selling an infusion services business requires more than simply identifying buyers. Achieving the strongest outcomes depends on positioning the business around the factors that investors value most.

Agenda Health helps infusion services owners prepare for a successful transaction by leveraging our deep industry knowledge and M&A expertise. Our team works closely with founders and operators to highlight the strengths of their platform—whether that includes strong referral networks, diversified therapies, attractive payer mix, or scalable operations.

Through our vetted network of strategic acquirers and healthcare-focused investors, Agenda Health connects infusion providers with the right partners while guiding owners through every stage of the transaction process.

Thinking About Selling?

With 30+ years of combined healthcare M&A expertise and over $600M in transaction value, we’ll give you a clear, honest assessment of your business’s worth. We specialize in healthcare services and will help you understand all your options, whether you’re ready to transition now or planning for the future.

Completed Transactions

Client Success Stories in Infusion Services

It seems we can’t find what you’re looking for.

Hear From Our Partners

Insights from Those We’ve Served

Hear from those who have gone before you and learn how our unique approach has helped healthcare organizations like yours achieve their transition goals and sell their business.

Close
Close
Close